Literature DB >> 8388646

ATP and adenosine 3',5'-cyclic monophosphate stimulate the synthesis of surfactant protein A in rat lung.

A Wali1, M F Beers, C Dodia, S I Feinstein, A B Fisher.   

Abstract

Synthesis and secretion of surfactant protein A (SP-A) were studied in the isolated perfused rat lung using Trans35S-label (approximately 85% methionine, 15% cysteine) in the perfusate with or without 1 mM ATP or 0.1 mM 8-bromoadenosine 3',5',-cyclic monophosphate (8-BrcAMP) for up to 6 h of perfusion. By enzyme-linked immunosorbent assay, the SP-A content was 36 +/- 0.3% of total protein in extracellular surfactant and 10.8 +/- 1.9% of total protein in lamellar bodies of control lungs; these relativr proportions were maintained in the presence of ATP or 8-BrcAMP. Incorporation of [35S]methionine (cysteine) into the surfactant and lamellar body protein fraction could be detected at 4 h of perfusion. At 6 h, specific activity of total protein [disintegrations per minute (dpm)/micrograms)] was significantly increased in both the surfactant (54%) and lamellar body fractions (30%) under the influence of either secretagogue compared with control conditions. In the presence of ATP, there was a significant increase in the SP-A immunoprecipitable counts of 61 and 72% in extra- and intracellular compartments, respectively. However, no significant change was observed in the relative abundance of SP-A mRNA between control and secretagogue-treated lungs. This dissociation of SP-A mRNA abundance and label incorporation into protein indicates that alteration in translational efficiency or posttranslational factors may be involved in the secretagogue-induced stimulation of SP-A synthesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388646     DOI: 10.1152/ajplung.1993.264.5.L431

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

1.  Alveolar surfactant protein D content modulates bleomycin-induced lung injury.

Authors:  John Casey; Jennifer Kaplan; Elena N Atochina-Vasserman; Andrew J Gow; Helchem Kadire; Yaniv Tomer; James H Fisher; Samuel Hawgood; Rashmin C Savani; Michael F Beers
Journal:  Am J Respir Crit Care Med       Date:  2005-06-30       Impact factor: 21.405

2.  Pathway to lamellar bodies for surfactant protein A.

Authors:  Aron B Fisher; Chandra Dodia; Peter Ruckert; Jian-Qin Tao; Sandra R Bates
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-09       Impact factor: 5.464

3.  Surfactant protein-A inhibits Aspergillus fumigatus-induced allergic T-cell responses.

Authors:  Seth Thomas Scanlon; Tatyana Milovanova; Sonja Kierstein; Yang Cao; Elena N Atochina; Yaniv Tomer; Scott J Russo; Michael F Beers; Angela Haczku
Journal:  Respir Res       Date:  2005-08-24

4.  Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species.

Authors:  Elena N Atochina; James M Beck; Angela M Preston; Angela Haczku; Yaniv Tomer; Seth T Scanlon; Trevor Fusaro; John Casey; Samuel Hawgood; Andrew J Gow; Michael F Beers
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.